Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Variations to Marketing Authorisations in the EU Seminar - London, United Kingdom - November 16th, 2016 - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "Variations to Marketing Authorisations in the EU" conference to their offering.

Review of the Variations Regulations. Update on Mutual Recognition/Decentralised, Centralised and National Variations (with emphasis on UK and Ireland)

- An introduction to the EC system for Variations

- The Current Variations Regulations of the European Commission and procedures in practice

- Review of latest requirements

- Biologicals and Biotech

- Pharmaceutical and Clinical Variations

- Practical advice on the preparation and submission of Variation applications

This meeting will give an introduction of the EC system for Variations with practical advice on the preparation and submission of Variation applications using the various European procedures.

There will be a review of experience with the latest Variation Regulations and of the available guidance on how they are being implemented.

Agenda

09.00 Registration and Coffee

9.30 The Current Variations Regulations of the European Commission and procedures in Practice

- Types of Variation

- How to submit a Variation

- Procedural and Practical Guidance

- Processing timescales

11.00 Coffee

11.15 The Variations Regulations: the Industry view

- Examples of current experience

- Common reasons for invalid applications

- Tips of working with the variation application form

12.30 Lunch

13.30 Variations Workshop (Classification and Grouping)

14.45 Tea

15.00 Clinical Variations

- New indications

- Extension of products into new patient groups

- Supporting data and Expert Reports, including requirements for generic products

- Amendments to safety information

13.45 Pharmaceutical Variations (chemicals, biologicals and biotech)

- Type II variations versus line extensions

- Variations involving the submission of Certificates of Suitability (CEP)

- Drug Master Files

- Quality Overall Summaries (Expert Reports)

16.30 End of meeting

For more information about this conference visit http://www.researchandmarkets.com/research/w2pg2q/variations_to

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006216/en/

Business Wire
www.businesswire.com

Last updated on: 05/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.